Ponte Vedra pharmaceutical company debuts on Nasdaq - Jacksonville Business Journal

A biopharmaceutical startup led by the former CEO of one Jacksonville's fastest-growing companies debuted on the Nasdaq stock exchange on Friday, priced at $5 a share.

The drug being developed by Cadrenal is an oral anti-coagulant that Pham has previously said could replace warfarin as a standard medication. The company is looking to sell 1.4 million shares of stock, raising $7 million before expenses. Various existing shareholders, including the Boys & Girls Club of Northeast Florida, are expected to sell another 1.7 million shares.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Jacksonville hospitals ranked among best in U.S. by Healthgrades - Jacksonville Business JournalMayo Clinic and a pair of HCA facilities made the exclusive list. How much did these hospitals pay Healthgrades for their rankings?
La source: JaxBizJournal - 🏆 599. / 51 Lire la suite »

Mark Cuban on disrupting the pharmaceutical industry - CEO SpotlightMark Cuban, CEO of Cuban Companies, joins David Johnson on this episode of CEO Spotlight.
La source: KRLD - 🏆 75. / 68 Lire la suite »

Study: Florida among states with most new home builds - Jacksonville Business JournalUtah is the state with the most new construction homes being developed, with 11.7 new builds per 1,000 residents.
La source: JaxBizJournal - 🏆 599. / 51 Lire la suite »